Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Dopamine therapy"'
Autor:
Brenton A Wright, Ece Bayram, Deborah L. Harrington, Qian Shen, Irene Litvan, Cailey Grembowski
Publikováno v:
Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition, vol 28, iss 6
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn
Visuospatial working memory (WM) impairments in Parkinson's disease (PD) are more prominent and evolve earlier than verbal WM deficits, suggesting some differences in underlying pathology. WM is regulated by dopaminergic neurotransmission in the pref
Dopaminergic medication improves cognitive control under low cognitive demand in Parkinson’s disease
Publikováno v:
Neuropsychology. 34:551-559
OBJECTIVE Dopamine agonists are the main pharmacological intervention for the motor symptoms of Parkinson's disease (PD). However, dopaminergic medication has been associated with disinhibitory psychopathology in some patients. The aim of this study
Autor:
Giuseppe Di Lorenzo, Lilla Bonanno, Silvia Marino, Nancy Drago, Rosanna Palmeri, Chiara Sorbera, Viviana Lo Buono, Vincenzo Cimino, Alessia Bramanti, Cettina Allone
Publikováno v:
Journal of geriatric psychiatry and neurology. 33(5)
Introduction: Parkinson disease (PD) is a neurodegenerative disorder characterized by motor and nonmotor symptoms. The impaired ability to recognize facial emotion expressions represents an important nonmotor symptom. The aim of this study is to inve
Publikováno v:
Antioxidants
Volume 9
Issue 11
Antioxidants, Vol 9, Iss 1159, p 1159 (2020)
Volume 9
Issue 11
Antioxidants, Vol 9, Iss 1159, p 1159 (2020)
Few studies have reported on changes to oxidative stress and mitochondrial DNA copy numbers in patients with Parkinson&rsquo
s disease (PD), particularly those undergoing long-term dopamine therapy. This study measured mitochondrial copy numbers
s disease (PD), particularly those undergoing long-term dopamine therapy. This study measured mitochondrial copy numbers
Autor:
Ya-Chen Lin, Robert M. Kessler, Adam J. Stark, Daniel O. Claassen, Paula Trujillo, Nelleke C. van Wouwe, Hakmook Kang, Christopher T. Smith, Kalen J. Petersen, Manus J. Donahue, David H. Zald
Publikováno v:
The Journal of Neuroscience. 38:3230-3239
The nigrostriatal and mesocorticolimbic dopamine networks regulate reward-driven behavior. Regional alterations to mesolimbic dopamine D2/3receptor expression are described in drug-seeking and addiction disorders. Parkinson's disease (PD) patients ar
Autor:
Michael S. Okun, Kelly D. Foote, Aysegul Gunduz, P. Justin Rossi, Christopher W. Hess, Daniel Martinez-Ramirez, Sol De Jesus
Publikováno v:
Parkinsonism & Related Disorders. 44:13-17
Introduction Recent evidence suggests deep brain stimulation can alter impulse control. Our objective was to prospectively evaluate the effects of subthalamic nucleus (STN) and globus pallidus internus (GPi) deep brain stimulation on impulse control
Autor:
David H. Zald, Nelleke C. van Wouwe, Adam J. Stark, Robert M. Kessler, Daniel O. Claassen, Charis A. Spears, Kalen J. Petersen, Manus J. Donahue
Publikováno v:
Movement Disorders. 32:1574-1583
Background PD patients treated with dopamine therapy can develop maladaptive impulsive and compulsive behaviors, manifesting as repetitive participation in reward-driven activities. This behavioral phenotype implicates aberrant mesocorticolimbic netw
Autor:
Annemette Løkkegaard, Allan Lohse, David Meder, Hartwig R. Siebner, Silas Haahr Nielsen, Damian M. Herz, Anders Elkjær Lund
Publikováno v:
Brain Communications
Lohse, A, Meder, D, Nielsen, S, Lund, A E, Herz, D M, Løkkegaard, A & Siebner, H R 2020, ' Low-frequency transcranial stimulation of pre-supplementary motor area alleviates levodopa-induced dyskinesia in Parkinson's disease : a randomized cross-over trial ', Brain Communications, vol. 2, no. 2, pp. fcaa147 . https://doi.org/10.1093/braincomms/fcaa147
Lohse, A, Meder, D, Nielsen, S, Lund, A E, Herz, D M, Løkkegaard, A & Siebner, H R 2020, ' Low-frequency transcranial stimulation of pre-supplementary motor area alleviates levodopa-induced dyskinesia in Parkinson's disease : a randomized cross-over trial ', Brain Communications, vol. 2, no. 2, pp. fcaa147 . https://doi.org/10.1093/braincomms/fcaa147
Levodopa-induced dyskinesia gradually emerges during long-term dopamine therapy, causing major disability in patients with Parkinson disease. Using pharmacodynamic functional MRI, we have previously shown that the intake of levodopa triggers an exces
Autor:
Maki Oiwa-Monna, Satoshi Takahashi, Takaaki Konuma, Masamichi Isobe, Arinobu Tojo, Seiko Kato, Mai Mizusawa
Publikováno v:
Bone marrow transplantation. 54(12)
Early fluid overload has been associated with poor transplant outcomes after allogeneic hematopoietic cell transplantation. However, its effects on the outcomes after cord blood transplantation (CBT) are unclear. We retrospectively analyzed the data
Autor:
Barbara Sochanowicz, Marta Oknińska, Urszula Mackiewicz, Przemysław Leszek, Michal Maczewski, Aleksandra Paterek, Marcin Kruszewski, Witold Śmigielski
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 136, Iss, Pp 111250-(2021)
Background: Exacerbations of chronic heart failure (CHF) are often treated with catecholamines to provide short term inotropic support, but this strategy is associated with long-term detrimental hemodynamic effects and increased ventricular arrhythmi